🇺🇸 Aminophyllin in United States

FDA authorised Aminophyllin on 19 April 1940

Marketing authorisations

FDA — authorised 19 April 1940

  • Application: NDA002386
  • Marketing authorisation holder: GD SEARLE LLC
  • Local brand name: AMINOPHYLLIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA — authorised 24 May 1982

  • Application: ANDA087243
  • Marketing authorisation holder: GD SEARLE LLC
  • Local brand name: AMINOPHYLLIN
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

FDA

  • Status: approved

FDA

  • Application: ANDA087621
  • Marketing authorisation holder: GD SEARLE LLC
  • Local brand name: AMINOPHYLLIN
  • Indication: INJECTABLE — INJECTION
  • Status: approved

Read official source →

Other Respiratory approved in United States

Frequently asked questions

Is Aminophyllin approved in United States?

Yes. FDA authorised it on 19 April 1940; FDA authorised it on 24 May 1982; FDA has authorised it.

Who is the marketing authorisation holder for Aminophyllin in United States?

GD SEARLE LLC holds the US marketing authorisation.